Two TB survivors fight Johnson & Johnson monopoly bid

At present, only 2% of over 1.47 lakh patients suffering from multi drug resistant TB in India are currently getting Bedaquiline.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news